Stocks TelegraphStocks Telegraph
Stock Ideas

NTLA Financial Statements and Analysis

NASDAQ : NTLA

Intellia Therapeutics, Inc.

$9.62
0.08+0.84%
At Close 4:00 PM
62.64
BESG ScoreESG Rating

NTLA FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

NTLA Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue9.111M6.957M28.935M-1.917M11.992M
cost of revenue02.599M2.512M2.466M2.29M
gross profit9.111M4.358M26.423M-4.383M9.702M
gross profit ratio1.000.6260.9132.2860.809
research and development expenses123.38M111.608M109.335M108.981M113.696M
general and administrative expenses30.501M31.793M31.091M28.994M29.403M
selling and marketing expenses00000
selling general and administrative expenses30.501M31.793M31.091M28.994M29.403M
other expenses0-114.207M000
operating expenses153.881M143.401M140.426M137.975M143.099M
cost and expenses153.881M146.00M142.938M137.975M143.099M
interest income12.122M12.422M12.632M12.459M12.74M
interest expense0008.832M0
depreciation and amortization2.608M2.599M2.512M2.466M2.29M
ebitda-142.162M-136.444M-111.491M-137.426M-131.107M
ebitda ratio-15.603-19.612-3.85371.688-10.933
operating income-144.77M-139.043M-114.003M-139.892M-131.107M
operating income ratio-15.89-19.986-3.9472.974-10.933
total other income expenses net9.058M-7.932M6.567M-4.728M-3.857M
income before tax-135.712M-146.975M-107.436M-132.161M-122.224M
income before tax ratio-14.895-21.126-3.71368.942-10.192
income tax expense002.469M40.635M-15.03M
net income-135.712M-146.975M-107.436M-132.161M-122.224M
net income ratio-14.895-21.126-3.71368.942-10.192
eps-1.34-1.52-1.12-1.46-1.38
eps diluted-1.34-1.52-1.12-1.46-1.38
weighted average shs out101.002M96.975M95.502M90.461M88.645M
weighted average shs out dil101.002M96.975M95.502M90.461M88.645M
Graph

NTLA Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents120.495M130.849M171.979M226.748M168.027M
short term investments537.619M560.219M619.315M685.475M686.761M
cash and short term investments658.114M691.068M791.294M912.223M992.54M
net receivables8.854M12.329M36.427M36.456M6.491M
inventory001.000-137.752M
other current assets43.934M53.814M56.322M49.651M32.214M
total current assets710.902M757.211M884.043M998.33M893.493M
property plant equipment net129.094M135.685M142.499M148.135M152.575M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments316.52M262.41M175.695M154.512M197.281M
tax assets00000
other non current assets16.835M36.23M57.352M00
total non current assets462.449M434.325M375.546M302.647M349.856M
other assets001.0000
total assets1.173B1.192B1.26B1.301B1.243B
account payables13.145M18.816M13.689M7.452M3.553M
short term debt19.177M37.926M18.763M18.599M17.074M
tax payables00000
deferred revenue22.155M22.184M22.184M22.14M13.347M
other current liabilities51.206M26.164M43.276M67.017M57.979M
total current liabilities105.683M105.09M97.912M115.208M91.953M
long term debt82.446M87.332M92.10M96.747M101.263M
deferred revenue non current22.607M28.052M33.44M38.853M12.719M
deferred tax liabilities non current00-33.44M00
other non current liabilities00000
total non current liabilities105.053M115.384M125.54M135.60M113.982M
other liabilities01.001.0000
capital lease obligations101.623M87.332M92.10M115.346M118.337M
total liabilities210.736M220.474M223.452M250.808M205.935M
preferred stock00000
common stock10.00K10.00K10.00K9.00K9.00K
retained earnings-2.049B-1.913B-1.766B-1.658B-1.526B
accumulated other comprehensive income loss3.297M-1.155M-947.00K-2.258M-3.572M
other total stockholders equity3.008B2.885B2.803B2.711B2.567B
total stockholders equity962.615M971.062M1.036B1.05B1.037B
total equity962.615M971.062M1.036B1.05B1.037B
total liabilities and stockholders equity1.173B1.192B1.26B1.301B1.243B
minority interest00000
total investments854.139M822.629M795.01M728.358M729.124M
total debt101.623M106.295M110.863M115.346M118.337M
net debt-18.872M-24.554M-61.116M-111.402M-49.69M
Graph

NTLA Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax0007.157M-4.076M
stock based compensation39.619M40.861M34.176M35.043M35.352M
change in working capital103.00K29.624M-29.727M3.11M-13.691M
accounts receivables3.474M24.099M29.00K-29.965M-1.434M
inventory000-8.647M4.235M
accounts payables-5.552M5.347M5.569M3.941M-7.706M
other working capital35.147M178.00K-35.325M37.781M-8.786M
other non cash items8.545M32.318M13.415M-8.669M968.00K
net cash provided by operating activities-84.837M-58.186M-120.662M-93.054M-101.381M
investments in property plant and equipment-1.279M-1.012M-2.506M-1.52M-4.332M
acquisitions net00000
purchases of investments-206.103M-300.81M-259.558M-149.775M-129.37M
sales maturities of investments178.706M277.632M267.965M197.234M213.202M
other investing activites20.967M-23.178M8.407M00
net cash used for investing activites-7.709M-24.19M5.901M45.939M79.50M
debt repayment00000
common stock issued75.691M41.246M59.992M103.611M14.718M
common stock repurchased00000
dividends paid00000
other financing activites6.501M41.246M59.992M2.873M4.384M
net cash used provided by financing activities82.192M41.246M59.992M106.484M19.102M
effect of forex changes on cash000-122.398M0
net change in cash3.251M-41.13M-54.769M59.369M-2.779M
cash at end of period134.10M130.849M171.979M240.353M180.984M
cash at beginning of period130.849M171.979M226.748M180.984M183.763M
operating cashflow-84.837M-58.186M-120.662M-93.054M-101.381M
capital expenditure-1.279M-1.012M-2.506M-1.52M-4.332M
free cash flow-86.116M-59.198M-123.168M-94.574M-105.713M
Graph

Frequently Asked Questions

How did Intellia Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, NTLA generated $9.11M in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Intellia Therapeutics, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Intellia Therapeutics, Inc. reported a $9.11M Gross Profit for the quarter ended Sep 30, 2024.

Have NTLA's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. NTLA incurred $153.88M worth of Operating Expenses, while it generated -$144.77M worth of Operating Income.

How much Net Income has NTLA posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Intellia Therapeutics, Inc., the company generated -$135.71M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Intellia Therapeutics, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Intellia Therapeutics, Inc. as of the end of the last quarter was $120.50M.

What are NTLA's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, NTLA had Total Net Receivables of $8.85M.

In terms of Total Assets and Current Assets, where did Intellia Therapeutics, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of NTLA were $710.90M, while the Total Assets stand at $1.17B.

As of the last quarter, how much Total Debt did Intellia Therapeutics, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of NTLA's debt was $101.62M at the end of the last quarter.

What were NTLA's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, NTLA reported total liabilities of $210.74M.

How much did NTLA's Working Capital change over the last quarter?

Working Capital Change for NTLA was $103.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

NTLA generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. NTLA generated -$84.84M of Cash from Operating Activities during its recently reported quarter.

What was NTLA's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. NTLA reported a $3.25M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph